Loading the player… Onxeo Just Announced Acquisition of DNA Therapeutics and Provides Update on Portfolio. “Onxeo S.A. , an innovative company specializing in the development of orphan oncology therapeutics, today announced that it has reached an agreement to acquire DNA Therapeutics, a privately-held, clinical-stage biopharmaceutical company, for its signal-interfering DNA repair technology, which is directed at […]

Read more